Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| MET | P08581 | Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) | Cancer-related genesDisease related genesEnzymes | 1 | DeafnessNon-syndromic deafnessAlzheimer disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.40 | ||
| NTNG2 | Q96CW9 | Netrin-G2 (Laminet-2) | Disease related genesHuman disease related genesPredicted intracellular proteins | Autism spectrum disorderIntellectual disability | Adhesion and uptake mediationMetabolism mediation | 3 | 0.40 | |||
| NTRK2 | Q16620 | BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B) | Cancer-related genesDisease related genesEnzymes | 1 | EpilepsyObesity | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 3 | 0.40 | ||
| PDE4A | P27815 | 3',5'-cyclic-AMP phosphodiesterase 4A (EC 3.1.4.53) (DPDE2) (PDE46) (cAMP-specific phosphodiesterase 4A) | EnzymesFDA approved drug targetsMetabolic proteins | Acute upper respiratory infectionAllergic/hypersensitivity disorderAmyloidosis | Clinical-translation mediationReceptor-signaling mediation | 3 | 0.40 | |||
| PGAP3 | Q96FM1 | GPI-specific phospholipase A2-like PGAP3 (EC 3.1.1.-) (COS16 homolog) (hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1) (Post-GPI attachment to proteins factor 3) | Disease related genesHuman disease related genesPredicted intracellular proteins | 7 | Intellectual disability | Metabolism mediation | 3 | 0.40 | ||
| PGFRA | P16234 | Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a) | Cancer-related genesCD markersDisease related genes | 1 | Acute myeloid leukaemiaBCR-ABL1-negative chronic myeloid leukaemiaBrain cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.40 | ||
| TAU | P10636 | Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) | Candidate cardiovascular disease genesDisease related genesFDA approved drug targets | Alzheimer diseaseAcute myeloid leukaemiaCentral nervous system disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.40 | |||
| TNR16 | P08138 | Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (Low-affinity nerve growth factor receptor p75NGFR) (Low-affinity nerve growth factor receptor p75NGR) (p75 ICD) (CD antigen CD271) | Cancer-related genesCD markersPredicted intracellular proteins | 1 | Alzheimer diseaseCerebral ischaemiaChronic pain | Clinical-translation mediationMetabolism mediationReceptor-signaling mediation | 3 | 0.40 | ||
| 4F2 | P08195 | Amino acid transporter heavy chain SLC3A2 (4F2 cell-surface antigen heavy chain) (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98) | Cancer-related genesCD markersEssential proteins | 1 | Acute myeloid leukaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.40 | ||
| ANPRA | P16066 | Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) | 1 | AsthmaGeneral pain disorderHeart disease | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.40 |